171 related articles for article (PubMed ID: 537884)
41. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
Maes P
J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
[TBL] [Abstract][Full Text] [Related]
42. [Possible errors in the interpretation of bacterial sensitivity to aminoglycoside antibiotics].
García Hierro P; Ponte Miramontes MC; Soriano García F
Rev Clin Esp; 1980 Oct; 159(2):87-90. PubMed ID: 7209044
[No Abstract] [Full Text] [Related]
43. [Activity of various semisynthetic aminoglycoside antibiotics on gentamicin-sensitive and gentamicin-resistant bacterial populations].
Zemelman R; Bello H; Mondaca MA
Rev Med Chil; 1983 Mar; 111(3):255-61. PubMed ID: 6648106
[No Abstract] [Full Text] [Related]
44. [Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
Cuena Boy R; Azanza Perea JR; Echeverría Echepare LM; Honorato Pérez J
Rev Med Univ Navarra; 1983 Dec; 27(4):21-7. PubMed ID: 6676898
[No Abstract] [Full Text] [Related]
45. [Sensitivity in vitro of 192 Proteus strains to several aminoglycosides].
Thaller MC; Berchicchi R; Berlutti F; Maragoni F; Dainelli B
Ann Sclavo; 1981; 23(1):57-63. PubMed ID: 7294918
[TBL] [Abstract][Full Text] [Related]
46. Ototoxicity of tobramycin, gentamicin, amikacin and sisomicin in the guinea pig.
Brummett RE; Fox KE; Bendrick TW; Himes DL
J Antimicrob Chemother; 1978 May; 4 Suppl A():73-83. PubMed ID: 659353
[No Abstract] [Full Text] [Related]
47. Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
Husson MO; Izard D; Leclerc H
Drugs Exp Clin Res; 1986; 12(4):325-7. PubMed ID: 3459642
[TBL] [Abstract][Full Text] [Related]
48. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Murray PR
Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of in vitro activity of 3 aminoglycosides: sisomicin, tobramycin and gentamycin].
Grima P
G Ital Chemioter; 1978; 25(1):49-51. PubMed ID: 751849
[No Abstract] [Full Text] [Related]
50. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
Minshew BH; Pollock HM; Schoenknecht FD; Sherris JC
Antimicrob Agents Chemother; 1977 Dec; 12(6):688-96. PubMed ID: 412464
[TBL] [Abstract][Full Text] [Related]
51. Clinical and microbiologic consequences of amikacin use during a 42-month period.
Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
[TBL] [Abstract][Full Text] [Related]
52. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
Hostacká A
J Basic Microbiol; 1998; 38(5-6):383-8. PubMed ID: 9871334
[TBL] [Abstract][Full Text] [Related]
53. [Comparison of the antibacterial effects of gentamycin, tobramycin, dibekacin and amikacin in urinary germs].
Rothenberger K; Friesen A; Streifinger W; Hofstetter A
Fortschr Med; 1981 Oct; 99(40):1669-72. PubMed ID: 7298004
[TBL] [Abstract][Full Text] [Related]
54. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
Schassan HH; Witt U
Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
[TBL] [Abstract][Full Text] [Related]
55. [Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
Vincent P; Vachée A; Izard D
Pathol Biol (Paris); 1997 Nov; 45(9):771-5. PubMed ID: 9538477
[TBL] [Abstract][Full Text] [Related]
56. Potentiation of magnesium sulfate--induced neuromuscular weakness by gentamicin, tobramycin, and amikacin.
L'Hommedieu CS; Nicholas D; Armes DA; Jones P; Nelson T; Pickering LK
J Pediatr; 1983 Apr; 102(4):629-31. PubMed ID: 6834204
[No Abstract] [Full Text] [Related]
57. [Studies on the antimicrobial activities of gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa isolated at Hokkaido University Hospital].
Sato K; Matsumiya H; Saito A
Jpn J Antibiot; 1982 May; 35(5):1240-8. PubMed ID: 6813532
[TBL] [Abstract][Full Text] [Related]
58. In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
Watanakunakorn C
Antimicrob Agents Chemother; 1983 Aug; 24(2):305-6. PubMed ID: 6314890
[TBL] [Abstract][Full Text] [Related]
59. The new aminoglycoside antibiotics.
Fields BT
J Ark Med Soc; 1976 Aug; 73(3):141-4. PubMed ID: 134018
[No Abstract] [Full Text] [Related]
60. Gentamicin and amikacin---an in vitro comparison using 1000 clinical isolates.
Forgan-Smith WR; McSweeney RJ
Aust N Z J Med; 1978 Aug; 8(4):383-6. PubMed ID: 282852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
